PIM in normal renal function patients (n = 294) | PIM in renal impaired patients (n = 127) | |
---|---|---|
Frequency (%) | Frequency (%) | |
Long-acting sulfonylurea | 76 (25.7%) | 26(20.4%) |
Alpha-blockers | 12(4.1%) | 6(4.7%) |
Proton pump inhibitors | 6(2.0%) | 6(4.7%) |
NSAID | 8(2.7%) | 5(3.9%) |
Digoxin | 4(1.4%) | 4(3.1%) |
Antihistamine | 3(1.0%) | 3(2.4%) |
CNS medication | 7(2.4%) | 2(1.6%) |
Anti-Parkinson | 3(1%) | 1(0.8%) |